Trials / Conditions / Alopecia, Androgenetic

Alopecia, Androgenetic

19 registered clinical trials studyying Alopecia, Androgenetic — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Efficacy and Safety of APSMNF in the Treatment of Male Androgenetic Alopecia NCT07516561	Apsen Farmaceutica S.A.	Phase 3
Active Not Recruiting	A Safety and Efficacy Study of PDFE-2304 Topical Solution for the Treatment of Androgenic Alopecia. NCT07011485	PDFE Pharma Innovations FZCO	Phase 2
Terminated	Assessment of Biological and Biometrological Parameters in Adult Subjects with Androgenetic Alopecia NCT06854432	Pierre Fabre Dermo Cosmetique	N/A
Unknown	Clinical Workflow Optimization Using Artificial Intelligence for Dermatological Conditions NCT06263413	AI Labs Group S.L	—
Completed	A Study to Evaluate the Efficacy and Safety of Clascoterone Solution in Treatment of Male Pattern Hair Loss (S NCT05914805	Cassiopea SpA	Phase 3
Active Not Recruiting	A Study to Evaluate the Efficacy and Safety of Clascoterone Solution in Treatment of Male Pattern Hair Loss NCT05910450	Cassiopea SpA	Phase 3
Completed	Study of TDM-105795 Following Topical Administration in Male Subjects With Androgenetic Alopecia NCT05802173	Technoderma Medicines Inc.	Phase 2
Unknown	Comparing Platelet-Rich Plasma (PRP) Centrifugation Methods on Thrombocyte Concentration and Clinical Improvem NCT05681897	Indonesia University	N/A
Completed	A Study of TDM-105795 in Male Subjects With Androgenetic Alopecia (AGA) NCT05244980	Technoderma Medicines Inc.	Phase 1
Completed	Adipose-derived Stem Cell Conditioned Media as a Novel Approach for Hair Regrowth in Male Androgenetic Alopeci NCT05296863	Dr. dr. Lili Legiawati, SpKK(K)	Phase 3
Completed	A Phase 1 Study of TDM-105795 Topical Solution in Male Subjects With Androgenetic Alopecia (AGA) NCT04913519	Technoderma Medicines Inc.	Phase 1
Unknown	Role of Vitamin D in Androgenetic Alopecia NCT03154528	Assiut University	—
Unknown	Hairstetics™ Anchoring System in Female Pattern Hair Loss (HAS-FPHL) NCT02316418	Hairstetics	N/A
Completed	Study to Evaluate the Efficacy and Safety of P-3074 Topical Solution in the Treatment of Androgenetic Alopecia NCT03004469	Polichem S.A.	Phase 3
Terminated	Safety, Tolerability, and Pharmacokinetics of Bimatoprost in Men With Androgenetic Alopecia (AGA) NCT02676310	Allergan	Phase 1
Completed	STYLE -- A Trial of Cell Enriched Adipose For Androgenetic Alopecia NCT02503852	Kerastem Technologies, LLC	N/A
Completed	A Safety and Efficacy Study of Bimatoprost in Men With Androgenic Alopecia (AGA) NCT01904721	Allergan	Phase 2
Completed	Safety and Efficacy Study of Bimatoprost in the Treatment of Men With Androgenic Alopecia NCT01325337	Allergan	Phase 2
Completed	Safety and Pharmacokinetics Study of New Formulation of Bimatoprost in Patients With Alopecia NCT01189279	Allergan	Phase 1